Breaking News Instant updates and real-time market news.

ELAN

Elanco

$16.95 /

-0.58 (-3.31%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

06:34
03/24/20
03/24
06:34
03/24/20
06:34

Elanco: Acquisition of Bayer's animal health business seen closing mid year

Elanco's (ELAN) excitement related to the addition of Bayer's (BAYRY) animal health business is unabated by the COVID-19 situation as it confirms the value of diversifying our companion animal business into the over-the-counter market. Likewise, the expanded global scale puts Elanco in a stronger position to weather tough business environments over the long-term as the combined company focuses on innovating to meet unmet needs of animals for veterinarians, farmers and pet owners across the globe. The pending acquisition continues to advance toward a mid-year 2020 closing. Elanco has received regulatory clearance in China, Colombia, Turkey and the Ukraine, and is continuing to collaborate with other key jurisdictions. Elanco has signed agreements to divest certain products it anticipates will be necessary to complete these reviews. Further, Elanco has fully secured financing to complete the transaction through its completed equity issuance and pricing of its Term Loan B earlier in the first quarter. Given the recent decline in interest rates, Elanco entered into derivative transactions to swap a portion of its floating interest rate on the $4.275B Term Loan B to a fixed rate obligation. These derivative transactions provide greater certainty on the Term Loan B interest expense. Elanco's first significant obligation after completing the acquisition is its $500M in senior notes due August 27, 2021. Both Bayer and Elanco continue to collaborate virtually, making significant progress toward Day 1 readiness, integration planning and value capture.

ELAN

Elanco

$16.95 /

-0.58 (-3.31%)

BAYRY

Bayer

$0.00 /

+ (+0.00%)

ELAN Elanco
$16.95 /

-0.58 (-3.31%)

01/10/20 Raymond James
Elanco well positioned in growing animal health market, says Raymond James
01/09/20 Raymond James
Elanco initiated with a Market Perform at Raymond James
12/19/19
Fly Intel: Top five analyst upgrades
12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
BAYRY Bayer
$0.00 /

+ (+0.00%)

03/13/20 Goldman Sachs
Bayer price target lowered to EUR 76 from EUR 77 at Goldman Sachs
03/11/20 Deutsche Bank
Deutsche Bank names Bayer as 'Catalyst Call' buy idea
03/04/20 Deutsche Bank
Bayer upgraded to Buy from Hold at Deutsche Bank

TODAY'S FREE FLY STORIES

Upgrade
Cheesecake Factory upgraded to Buy from Hold at Gordon Haskett » 06:16
03/31/20
03/31
06:16
03/31/20
06:16
CAKE

Cheesecake Factory

$16.51 /

+0.3 (+1.85%)

Gordon Haskett analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
HP Enterprise upgraded to Overweight from Equal Weight at Wells Fargo » 06:16
03/31/20
03/31
06:16
03/31/20
06:16
HPE

HP Enterprise

$10.04 /

+0.22 (+2.24%)

Wells Fargo analyst Aaron…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Capital Senior Living reports Q4 revenue $108.7M, consensus $109.31M » 06:15
03/31/20
03/31
06:15
03/31/20
06:15
CSU

Capital Senior Living

$0.60 /

-0.02 (-3.23%)

Reports Q4 adjusted CFFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Arena Pharmaceuticals initiated with a Buy at Guggenheim » 06:14
03/31/20
03/31
06:14
03/31/20
06:14
ARNA

Arena Pharmaceuticals

$42.12 /

-2.53 (-5.67%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Apache upgraded to Neutral from Sell at UBS » 06:14
03/31/20
03/31
06:14
03/31/20
06:14
APA

Apache

$4.10 /

-0.76 (-15.64%)

UBS analyst Lloyd Byrne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
FDA may extend application period for e-cigarette makers, WSJ reports » 06:13
03/31/20
03/31
06:13
03/31/20
06:13
MO

Altria Group

$37.28 /

+0.73 (+2.00%)

, BTI

British American Tobacco

$33.06 /

+0.71 (+2.19%)

, IMBBY

Imperial Brands

$0.00 /

+ (+0.00%)

, PM

Philip Morris

$72.53 /

+3.31 (+4.78%)

The FDA may give a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Radware says customer invests in additional application delivery solutions » 06:13
03/31/20
03/31
06:13
03/31/20
06:13
RDWR

Radware

$21.56 /

+0.33 (+1.55%)

Radware announced that a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
QEP Resources downgraded to Underweight from Neutral at Piper Sandler » 06:12
03/31/20
03/31
06:12
03/31/20
06:12
QEP

QEP Resources

$0.31 /

-0.0764 (-19.76%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Oasis Petroleum downgraded to Underweight from Neutral at Piper Sandler » 06:12
03/31/20
03/31
06:12
03/31/20
06:12
OAS

Oasis Petroleum

$0.30 /

-0.005 (-1.64%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Karuna Therapeutics initiated with a Buy at Guggenheim » 06:11
03/31/20
03/31
06:11
03/31/20
06:11
KRTX

Karuna Therapeutics

$70.40 /

+0.06 (+0.09%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
CytoDyn: FDA clears initiation of Phase 2 trial with leronlimab » 06:11
03/31/20
03/31
06:11
03/31/20
06:11
CYDY

CytoDyn

$0.00 /

+ (+0.00%)

CytoDyn announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Callon Petroleum downgraded to Underweight from Neutral at Piper Sandler » 06:11
03/31/20
03/31
06:11
03/31/20
06:11
CPE

Callon Petroleum

$0.53 /

-0.0547 (-9.42%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Hyatt execs who took pay cut could gain through stock awards, WSJ reports » 06:10
03/31/20
03/31
06:10
03/31/20
06:10
H

Hyatt

$48.49 /

-0.67 (-1.36%)

After furloughing hotel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Carvana price target lowered to $71 from $115 at JMP Securities » 06:09
03/31/20
03/31
06:09
03/31/20
06:09
CVNA

Carvana

$52.48 /

+3.48 (+7.10%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Imperial Brands upgraded to Overweight from Neutral at Piper Sandler » 06:09
03/31/20
03/31
06:09
03/31/20
06:09
IMBBY

Imperial Brands

$0.00 /

+ (+0.00%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ProQR Therapeutics announces budget review process » 06:09
03/31/20
03/31
06:09
03/31/20
06:09
PRQR

ProQR Therapeutics

$6.85 /

-0.4 (-5.52%)

The COVID-19 pandemic is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Diamondback Energy revises FY20 production view to 295.0 - 310.0 MBOE/d » 06:09
03/31/20
03/31
06:09
03/31/20
06:09
FANG

Diamondback Energy

$23.58 /

-0.29 (-1.21%)

Diamondback Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ProQR Therapeutics announces findings from Phase 1/2 Stellar trial » 06:07
03/31/20
03/31
06:07
03/31/20
06:07
PRQR

ProQR Therapeutics

$6.85 /

-0.4 (-5.52%)

ProQR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Cirrus Logic upgraded to Buy from Underperform at BofA » 06:07
03/31/20
03/31
06:07
03/31/20
06:07
CRUS

Cirrus Logic

$64.09 /

+2.22 (+3.59%)

BofA analyst Adam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Mosaic upgraded to Buy from Neutral at BofA » 06:07
03/31/20
03/31
06:07
03/31/20
06:07
MOS

Mosaic

$10.01 /

+0.115 (+1.16%)

BofA analyst Steve Byrne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
BlackRock CEO: Strategy for growth 'designed to withstand difficult periods' » 06:07
03/31/20
03/31
06:07
03/31/20
06:07
BLK

BlackRock

$454.61 /

+20.02 (+4.61%)

BlackRock CEO Larry Fink…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Coupa Software downgraded to Neutral from Overweight at Piper Sandler » 06:05
03/31/20
03/31
06:05
03/31/20
06:05
COUP

Coupa Software

$150.58 /

+4.12 (+2.81%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
HP Enterprise upgraded to Overweight from Equal Weight at Wells Fargo » 06:05
03/31/20
03/31
06:05
03/31/20
06:05
HPE

HP Enterprise

$10.04 /

+0.22 (+2.24%)

Wells Fargo analyst Aaron…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
BBX Capital provides update and announces workforce reduction in subsidiary » 06:05
03/31/20
03/31
06:05
03/31/20
06:05
BBX

BBX Capital

$2.24 /

+0.56 (+33.33%)

, BXG

Bluegreen Vacations

$5.32 /

+0.3 (+5.98%)

BBX Capital (BBX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Akero Therapeutics says three dose groups in BALANCED study met primary endpoint » 06:04
03/31/20
03/31
06:04
03/31/20
06:04
AKRO

Akero Therapeutics

$17.02 /

+0.93 (+5.78%)

Akero Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.